Janet Lambert

Janet Lambert

Company: ARM

Job title: CEO


PANEL DISCUSSION: How Prepared is the Industry for More Gene Therapy Approvals on the Horizon? 5:45 pm

As more gene therapy companies are entering or are in late-stage phase III trials, the industry need to prepare to navigate the challenges this will bring, including demands on manufacturing capacity, coming to agreements with payers, and ensuring patients are able to access these therapies. This panel will discuss: Current payer perspectives into gene therapy…Read more

day: Day Two

Understanding the Current Global Gene Therapy Landscape: What Can we Expect in 2022? 8:00 am

Exploring the current clinical trial landscape and products gearing up for approval Where are the key focus areas to continue the trend of rapid growth in gene therapy? Establishing the outlook for 2022: are we where we thought we would be this time last year?Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.